Journal for ImmunoTherapy of Cancer (Nov 2023)
812 Reprograming of tumor-associated myeloid cells by TLR9-targeted STAT3 antisense oligonucleotides sensitizes malignant glioma to PD1-specific immunotherapy
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)